Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Packaging & ContainerPharmaceutical Packaging

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1834230

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1834230

Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030

PUBLISHED:
PAGES: 314 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR of 15.8% during the forecast period.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million) Volume (Kilotons)
SegmentsType, Packaging Type, Drug Delivery, Raw Material, and Region
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

The pharmaceutical packaging market is witnessing significant growth opportunities, partly fueled by increasing demand for safe, reliable, and patient-centric packaging solutions across a variety of sectors, including hospitals, retail pharmacies, and e-pharmacies. Pharmaceutical packaging maintains the integrity of the product, stops it from becoming contaminated, and allows for convenient and safe delivery of the drug. In addition, as regulatory- and safety-motivated concerns mount, the US. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will push for greater requirements around materials, serialization, and anti-counterfeiting. Manufacturers of vehicles will begin increasing the conceptual development of good packaging systems, like those that are tamper-evident, child-resistant, and smart packaging. Safety, regulatory compliance, and packaging systems for children will push the industry to introduce digital and track-and-trace technologies, such as packaging enabled with RFID or QR codes. Pharmaceutical packaging will be moveable and influential in the ongoing evolution of investment in drug safety, product authenticity, and patient-specific features for a system of healthcare delivery in the future.

Pharmaceutical Packaging Market - IMG1

"By packaging type, primary packaging is projected to be the fastest-growing packaging type during the forecast period."

In the forecast period, primary packaging is projected to be the fastest-growing type of pharmaceutical packaging. This segment will grow because primary packaging is directly responsible for drug stability, sterility, and patient safety, particularly for more sensitive drugs, such as biologics and injectables. For example, the increasing demand for prefilled syringes, blister packs, vials, and ampoules indicates the manufacturing growth of pharmaceuticals and the desire for patients to have drugs packaged in more convenient formats ready for use. In addition, primary packaging is important in meeting regulatory challenges and serialization requirements. It also addresses concerns regarding tamper evidence and counterfeiting. Advances in barrier coatings, smart labels, and child-resistant closures will enhance functionality and product demand in global health care markets.

"By drug delivery, oral drugs are estimated to account for the second-largest market during the forecast period."

Oral drug delivery is estimated to account for the largest portion of the pharmaceutical packaging market in 2024 among the delivery methods for drug delivery systems. The packaging formats related to oral drug delivery are tablets, capsules, and oral liquids, primarily because of their convenience, affordability, and ability to promote adherence, or compliance, among patients. The packaging formats for oral solid doses will include blister packs and bottles, due to their portability, ability for unit dose, and ability to protect the dose from moisture and other contaminants. Increasing trend towards self-medication, in particular in the over-the-counter self-medication market, is also driving the demand for user-friendly oral drug delivery packaging. In addition, manufacturers continue to enhance oral drug packaging with sustainable aspects and easier access for older adults (e.g., easy-to-open and clearly labeled dosage designs).

"By raw material, paper & paperboard is set to account for the second-largest market share during the forecast period."

For the duration of the forecast period, paper & paperboard packaging is estimated to account for the second biggest market share in the pharmaceutical packaging market because this packaging type is mostly relevant to the secondary and tertiary packaging applications. The recyclable qualities of paper and paperboard materials, price advantage, and support for sustainability goals come to the forefront as pharmacy manufacturers respond to both societal and legislative pressures to limit plastic usage. The use of paperboard cartons, leaflets, and labels plays a key role in product identification, such as dose direction and legislative requirements for serialization and anti-counterfeiting, and tracking sustainability disposal practices. The sustainable focus on limited usage of plastics and overall desire to conform to the principles of a circular economy will continue to be drivers of the paper-based pharmaceutical packaging markets in developed regions, especially where sustainability initiatives are a priority.

"Asia Pacific is projected to account for the second-largest market share in the pharmaceutical packaging market during the forecast period."

In 2024, the Asia Pacific region accounted for the second largest share within the global pharmaceutical packaging market. The sustained strength of the region is principally based upon its growing pharmaceutical manufacturing base, particularly in emerging markets such as China, India, and Japan, which are prime markets for the development of generic and branded drug products. Growth in healthcare expenditures, a growing middle-class population, and improved access to healthcare services are increasing demand for pharmaceuticals, which is also driving demand for advanced pharmaceutical packaging offerings. This trend is also supported by an increase in chronic diseases and governmental policies aimed at establishing an effective domestic supply chain for medications, both for driving the need for safe and effective pharmaceutical packaging. The growth of contract manufacturing and pharmaceutical packaging services continues to expand in the Asia Pacific region, with attendant levels of investment from established companies, allowing these players to benefit from lower-cost production capabilities and scaled efficiencies. The combination of the previously outlined trends will substantiate the Asia Pacific region as a major contributor to the accelerated growth associated with the global pharmaceutical packaging market.

By Company Type: Tier 1: 25%, Tier 2: 42%, and Tier 3: 33%

By Designation: C-level Executives: 20%, Directors: 30%, and Other Designations: 50%

By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20%

Notes: Other designations include sales, marketing, and product managers.

Tier 1: Greater than USD 1 Billion; Tier 2: Between USD 500 million and USD 1 Billion; and Tier 3: Less than USD 500 million

Companies Covered: Amcor PLC (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO Corporation (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US) are covered in the report.

The study includes an in-depth competitive analysis of these key players in the pharmaceutical packaging market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmaceutical packaging market based on type (plastic bottles, blister packs, caps & closures, prefilled syringes, pouches & strips, prefilled inhalers, vials, ampoules, cartridges, labels & accessories, medical specialty bags, temperature-controlled packaging, medication tubes, and jars & canisters), drug delivery (oral drugs, pulmonary, transdermal, injectables, topical, nasal, ocular/ophthalmic and iv drugs), packaging type (primary and secondary) by raw material (plastics, paper & paperboard, and glass, metal) and region (Asia Pacific, North America, Europe, South America, and Middle East & Africa). The report's scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the pharmaceutical packaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, collaborations, mergers, acquisitions, product launches, and expansions, associated with the pharmaceutical packaging market. This report covers a competitive analysis of upcoming startups in the pharmaceutical packaging market ecosystem.

Reasons to Buy the Report

The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical packaging market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

Assessing the major drivers (growing healthcare expenditure and pharmaceutical industry in emerging economies, increasing demand for drug delivery devices and blister packaging, and technological advancements contributing to the growth of pharmaceutical packaging), restraints (increasing overall packaging costs owing to dynamic regulatory policies and lack of access to proper healthcare), opportunities (growing demand for primary pharmaceutical packaging and expansion of personalized medicine), and challenges (safeguarding against counterfeit products and balancing innovations with cost efficiency).

Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical packaging market.

Market Development: Comprehensive information about profitable markets - the report analyzes the pharmaceutical packaging market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US), among others.

Show more
Product Code: CH 3482

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 UNITS CONSIDERED
      • 1.3.4.1 Currency/Value unit
      • 1.3.4.2 Volume unit
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 GROWTH RATE FORECAST/ASSESSMENT
    • 2.5.1 SUPPLY SIDE
    • 2.5.2 DEMAND SIDE
  • 2.6 RISK ASSESSMENT
  • 2.7 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
  • 4.2 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
  • 4.3 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
  • 4.4 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
  • 4.5 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
  • 4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies
      • 5.2.1.2 Rising demand for drug delivery devices and blister packaging
      • 5.2.1.3 Technological advancements in pharmaceutical packaging
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increase in overall packaging costs due to dynamic regulatory policies
      • 5.2.2.2 Lack of access to proper healthcare in emerging economies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for primary pharmaceutical packaging
      • 5.2.3.2 Growth in personalized medicine
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Safeguarding counterfeit products
      • 5.2.4.2 Balancing innovations with cost efficiency
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.2 REGULATIONS
      • 5.6.2.1 21 CFR Part 211 - Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals (USA)
      • 5.6.2.2 Federal Anti-Tampering Act (USA, 1983)
      • 5.6.2.3 Fair Packaging and Labeling Act (FPLA, USA, 1967)
      • 5.6.2.4 Good Manufacturing Practices (GMP - WHO Guidelines)
      • 5.6.2.5 ISO 15378:2017 - Primary Packaging Materials for Medicinal Products
      • 5.6.2.6 European Pharmacopoeia (Ph. Eur.)
      • 5.6.2.7 United States Pharmacopeia (USP)
      • 5.6.2.8 Japanese Pharmacopoeia (JP)
      • 5.6.2.9 Regulation (EU) 2017/745 on Medical Devices (MDR - Europe)
      • 5.6.2.10 International Council for Harmonisation (ICH) Guidelines
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 392310)
    • 5.7.2 EXPORT SCENARIO (HS CODE 392310)
  • 5.8 PRICING ANALYSIS
    • 5.8.1 INDICATIVE AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY RAW MATERIAL
    • 5.8.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Nanotechnology
      • 5.9.1.2 Packaging food biologics
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Smart packaging
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Anti-counterfeit technology
  • 5.10 PATENT ANALYSIS
    • 5.10.1 INTRODUCTION
    • 5.10.2 LEGAL STATUS OF PATENTS
    • 5.10.3 JURISDICTION ANALYSIS
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY
    • 5.11.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING
    • 5.11.3 STREAMLINING OPERATIONS AND REDUCING COSTS THROUGH MD LOGISTICS
  • 5.12 KEY CONFERENCES AND EVENTS
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 IMPACT OF GEN AI/AI ON PHARMACEUTICAL PACKAGING MARKET
    • 5.14.1 INTRODUCTION
    • 5.14.2 AI-POWERED TRACKING AND BLOCKCHAIN INTEGRATION
    • 5.14.3 ENHANCING PHARMACEUTICAL SECURITY THROUGH AI
    • 5.14.4 SMART AND CONNECTED DRUG PACKAGING
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 THREAT OF NEW ENTRANTS
    • 5.15.2 THREAT OF SUBSTITUTES
    • 5.15.3 BARGAINING POWER OF BUYERS
    • 5.15.4 BARGAINING POWER OF SUPPLIERS
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 MACROECONOMIC ANALYSIS
    • 5.17.1 INTRODUCTION
    • 5.17.2 GDP TRENDS AND FORECASTS
  • 5.18 IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL PACKAGING MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 IMPACT ON COUNTRY/REGION
      • 5.18.3.1 US
      • 5.18.3.2 Europe
      • 5.18.3.3 Asia Pacific
    • 5.18.4 IMPACT ON TYPES
      • 5.18.4.1 Plastic bottles
      • 5.18.4.2 Medication tubes
      • 5.18.4.3 Other types

6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE

  • 6.1 INTRODUCTION
  • 6.2 PRIMARY
    • 6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
  • 6.3 SECONDARY
    • 6.3.1 RISE IN ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND

7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 7.1 INTRODUCTION
  • 7.2 PLASTIC
    • 7.2.1 EXCELLENT BARRIER PROPERTIES AND COST-EFFECTIVENESS TO DRIVE MARKET
    • 7.2.2 HIGH-DENSITY POLYETHYLENE
    • 7.2.3 POLYESTER
    • 7.2.4 POLYPROPYLENE
    • 7.2.5 LOW-DENSITY POLYETHYLENE
    • 7.2.6 POLYVINYL CHLORIDE
    • 7.2.7 CYCLIC OLEFIN COPOLYMER
    • 7.2.8 POLYETHYLENE TEREPHTHALATE
  • 7.3 PAPER & PAPERBOARD
    • 7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
  • 7.4 GLASS
    • 7.4.1 CHEMICAL RESISTANCE AND EFFECTIVE PROTECTION TO BOOST MARKET
  • 7.5 METAL
    • 7.5.1 INCREASE IN USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
  • 7.6 OTHER RAW MATERIALS

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY

  • 8.1 INTRODUCTION
  • 8.2 ORAL
    • 8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
  • 8.3 INJECTABLE 102 8.3.1 RISE IN USE OF BIOLOGICS TO BOOST MARKET
  • 8.4 TOPICAL
    • 8.4.1 RISE IN PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
  • 8.5 OCULAR/OPHTHALMIC
    • 8.5.1 INCREASE IN PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
  • 8.6 NASAL
    • 8.6.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
  • 8.7 PULMONARY
    • 8.7.1 RISE IN CASES OF LUNG DISORDERS TO DRIVE MARKET
  • 8.8 TRANSDERMAL
    • 8.8.1 RISE IN DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET
  • 8.9 INTRAVENOUS
    • 8.9.1 HIGH OCCURRENCE OF CHRONIC DISEASES TO DRIVE DEMAND
  • 8.10 OTHER DRUG DELIVERY MODES

9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 PLASTIC BOTTLES
    • 9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO DRIVE DEMAND
    • 9.2.2 STANDARD PLASTIC BOTTLES
    • 9.2.3 PLASTIC DISPENSING BOTTLES
    • 9.2.4 PLASTIC JARS
  • 9.3 BLISTER PACKS
    • 9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
    • 9.3.2 COMPARTMENT PACKS
    • 9.3.3 WALLET PACKS
  • 9.4 LABELS & ACCESSORIES
    • 9.4.1 STRINGENT GUIDELINES REGARDING DRUG INSTRUCTIONS TO DRIVE MARKET
    • 9.4.2 SELF-ADHESIVE
    • 9.4.3 DIE-CUT
    • 9.4.4 HOLOGRAPHIC STRIPS
    • 9.4.5 TAMPER-PROOF
    • 9.4.6 OTHER LABELS & ACCESSORIES
  • 9.5 CAPS & CLOSURES
    • 9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
  • 9.6 MEDICAL SPECIALTY BAGS
    • 9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
  • 9.7 PREFILLED SYRINGES
    • 9.7.1 RISE IN NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
  • 9.8 TEMPERATURE-CONTROLLED PACKAGING
    • 9.8.1 RISE IN DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
  • 9.9 POUCHES & STRIP PACKS
    • 9.9.1 RISE IN DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
  • 9.10 AMPOULES
    • 9.10.1 GROWTH IN DEMAND FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
  • 9.11 VIALS
    • 9.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE GROWTH
  • 9.12 PREFILLED INHALERS
    • 9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
    • 9.12.2 METERED DOSE INHALERS
    • 9.12.3 DRY POWDER INHALERS
  • 9.13 MEDICATION TUBES
    • 9.13.1 INCREASE IN DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
    • 9.13.2 COMPOSITE TUBES
    • 9.13.3 ALL-PLASTIC TUBES
    • 9.13.4 COLLAPSIBLE METAL TUBES
  • 9.14 JARS & CANISTERS
    • 9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
  • 9.15 CARTRIDGES
    • 9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
  • 9.16 OTHER TYPES

10 PHARMACEUTICAL PACKAGING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Rapid technological advancements in pharmaceutical packaging to fuel growth
    • 10.2.2 CANADA
      • 10.2.2.1 Expansion of pharmaceutical industry and increase in consumption of pharmaceutical products to boost market
    • 10.2.3 MEXICO
      • 10.2.3.1 Increase in chronic diseases and presence of free-trade agreements to fuel demand for pharmaceutical products
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Investment in innovations in biologics and sustainable materials, aligning with EU regulations on packaging waste reduction to drive market
    • 10.3.2 FRANCE
      • 10.3.2.1 High demand for generic drugs and investment in biotherapies to drive market
    • 10.3.3 ITALY
      • 10.3.3.1 Rise in exports of pharmaceuticals to boost market
    • 10.3.4 UK
      • 10.3.4.1 Innovations in drug manufacturing with reliable legal system and strong protection of intellectual property to drive market
    • 10.3.5 SPAIN
      • 10.3.5.1 High-quality, cost-effective manufacturing capabilities, well-established R&D facilities in healthcare sector to boost demand
    • 10.3.6 RUSSIA
      • 10.3.6.1 Government initiatives for domestic production of pharmaceuticals to fuel market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Increased investments in R&D of biologics and biosimilar drugs to drive market
    • 10.4.2 JAPAN
      • 10.4.2.1 Global leader in product innovation with sizeable aging population to drive demand for medications
    • 10.4.3 SOUTH KOREA
      • 10.4.3.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Large domestic consumption and export of generic drugs to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Wide adoption of Medicare and PBS schemes to drive market
    • 10.4.6 REST OF ASIA PACIFIC
  • 10.5 SOUTH AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 Large availability of required raw materials, cost-effective labor, and robust regulatory policies to boost market
    • 10.5.2 ARGENTINA
      • 10.5.2.1 Prevalence of noncommunicable diseases to boost market despite sharp economic deceleration, remediated by government stabilization measures
    • 10.5.3 REST OF SOUTH AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 SAUDI ARABIA
      • 10.6.1.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
    • 10.6.2 UAE
      • 10.6.2.1 Increasing initiatives for domestic pharmaceutical production to drive market
    • 10.6.3 SOUTH AFRICA
      • 10.6.3.1 Gradual rise in generic drug use to drive market
    • 10.6.4 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 MARKET SHARE ANALYSIS
  • 11.4 REVENUE ANALYSIS
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 11.5.1 COMPANY VALUATION
    • 11.5.2 FINANCIAL METRICS
  • 11.6 PRODUCT/BRAND COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Regional Footprint
      • 11.7.5.3 Raw material footprint
      • 11.7.5.4 Type footprint
      • 11.7.5.5 Drug delivery footprint
      • 11.7.5.6 Packaging type footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 AMCOR PLC (INCLUDING BERRY GLOBAL)
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products/Solutions/Services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
        • 12.1.1.3.3 Expansions
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 GERRESHEIMER AG
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products/Solutions/Services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 SCHOTT AG
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products/Solutions/Services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 APTARGROUP, INC.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products/Solutions/Services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
        • 12.1.4.3.2 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 BD
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products/Solutions/Services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
        • 12.1.5.3.3 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 WESTROCK COMPANY
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products/Solutions/Services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
      • 12.1.6.4 MnM view
    • 12.1.7 NIPRO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products/Solutions/Services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
      • 12.1.7.4 MnM view
    • 12.1.8 CATALENT, INC
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products/Solutions/Services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
        • 12.1.8.3.2 Expansions
      • 12.1.8.4 MnM view
    • 12.1.9 SEALED AIR
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products/Solutions/Services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product launches
        • 12.1.9.3.2 Deals
      • 12.1.9.4 MnM view
    • 12.1.10 WEST PHARMACEUTICAL SERVICES, INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products/Solutions/Services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches
        • 12.1.10.3.2 Deals
        • 12.1.10.3.3 Expansions
      • 12.1.10.4 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 ALPLA
    • 12.2.2 ARDAGH GROUP S.A.
    • 12.2.3 CCL INDUSTRIES INC.
    • 12.2.4 FRANK NOE
    • 12.2.5 GAPLAST GMBH
    • 12.2.6 LONZA
    • 12.2.7 MONDI
    • 12.2.8 NOLATO AB
    • 12.2.9 ORIGIN PHARMA PACKAGING
    • 12.2.10 COMAR
    • 12.2.11 BILCARE LIMITED
    • 12.2.12 SGD PHARMA
    • 12.2.13 SILGAN PLASTICS
    • 12.2.14 VETTER PHARMA INTERNATIONAL GMBH
    • 12.2.15 SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Product Code: CH 3482

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 SUMMARY OF CHANGES
  • TABLE 1 LIST OF KEY SECONDARY SOURCES
  • TABLE 2 RISK ASSESSMENT
  • TABLE 3 ROLES OF COMPANIES IN PHARMACEUTICAL PACKAGING ECOSYSTEM
  • TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 7 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 8 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 9 IMPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 10 EXPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 11 INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL PACKAGING OFFERED BY KEY PLAYERS, BY RAW MATERIAL, 2023-2030 (USD/KG)
  • TABLE 12 INDICATIVE AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING, BY REGION, 2023-2030 (USD/KG)
  • TABLE 13 PHARMACEUTICAL PACKAGING MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 14 IMPACT OF PORTER'S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES
  • TABLE 16 KEY BUYING CRITERIA FOR KEY TYPES
  • TABLE 17 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021-2028 (USD TRILLION)
  • TABLE 18 PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 19 PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KILOTON)
  • TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2025-2030 (KILOTON)
  • TABLE 24 PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 25 PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 26 PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 27 PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 28 PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 29 PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 30 TYPES OF GLASS USED FOR DIFFERENT PACKAGING
  • TABLE 31 PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 32 PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33 OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 34 OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 36 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 37 PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 38 PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39 PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 40 PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41 PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 42 PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43 PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 44 PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45 PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 46 PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47 PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 48 PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49 PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 50 PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51 PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 52 PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53 PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 54 PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 56 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 57 PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 58 PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59 PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 60 PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61 PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 62 PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63 PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 64 PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65 MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 66 MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67 PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 68 PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69 PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 70 PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71 PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 72 PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73 PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 74 PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75 PHARMACEUTICAL VIALS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 76 PHARMACEUTICAL VIALS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77 PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 78 PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79 PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 80 PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81 PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 82 PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83 PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 84 PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85 OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 86 OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 88 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 90 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KT)
  • TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (KT)
  • TABLE 101 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 102 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 103 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 104 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 105 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 106 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 107 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 108 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2025-2030 (USD MILLION)
  • TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KT)
  • TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (KT)
  • TABLE 119 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 120 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 121 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 122 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 123 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 124 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 125 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 126 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 127 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 128 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 129 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 130 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 131 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KT)
  • TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (KT)
  • TABLE 145 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 146 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 147 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 148 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 150 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 151 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 152 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 153 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 154 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 155 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 156 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 157 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 158 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KT)
  • TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (KT)
  • TABLE 169 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 170 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 171 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 172 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 173 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 174 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022-2024 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022-2024 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022-2024 (KT)
  • TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025-2030 (KT)
  • TABLE 187 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 188 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 191 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 192 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 193 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 194 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 195 PHARMACEUTICAL PACKAGING MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020-AUGUST 2025
  • TABLE 196 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 197 PHARMACEUTICAL PACKAGING MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 198 PHARMACEUTICAL PACKAGING MARKET: RAW MATERIAL FOOTPRINT, 2024
  • TABLE 199 PHARMACEUTICAL PACKAGING MARKET: TYPE FOOTPRINT, 2024
  • TABLE 200 PHARMACEUTICAL PACKAGING MARKET: DRUG DELIVERY FOOTPRINT, 2024
  • TABLE 201 PHARMACEUTICAL PACKAGING MARKET: PACKAGING TYPE FOOTPRINT, 2024
  • TABLE 202 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
  • TABLE 203 PHARMACEUTICAL PACKAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
  • TABLE 204 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020-AUGUST 2025
  • TABLE 205 PHARMACEUTICAL PACKAGING MARKET: DEALS, JANUARY 2020-AUGUST 2025
  • TABLE 206 PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS, JANUARY 2020-AUGUST 2025
  • TABLE 207 AMCOR PLC: COMPANY OVERVIEW
  • TABLE 208 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 209 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES
  • TABLE 210 PHARMACEUTICAL PACKAGING MARKET: DEALS
  • TABLE 211 PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS
  • TABLE 212 GERRESHEIMER AG: COMPANY OVERVIEW
  • TABLE 213 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 214 GERRESHEIMER AG: PRODUCT LAUNCHES
  • TABLE 215 GERRESHEIMER AG: DEALS
  • TABLE 216 GERRESHEIMER AG: EXPANSIONS
  • TABLE 217 SCHOTT AG: COMPANY OVERVIEW
  • TABLE 218 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 219 SCHOTT AG: PRODUCT LAUNCHES
  • TABLE 220 SCHOTT AG: DEALS
  • TABLE 221 SCHOTT AG: EXPANSIONS
  • TABLE 222 APTAR GROUP, INC.: COMPANY OVERVIEW
  • TABLE 223 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 224 APTAR GROUP, INC.: PRODUCT LAUNCHES
  • TABLE 225 APTAR GROUP, INC.: DEALS
  • TABLE 226 BD: COMPANY OVERVIEW
  • TABLE 227 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 228 BD: PRODUCT LAUNCHES
  • TABLE 229 BD: DEALS
  • TABLE 230 BD: EXPANSIONS
  • TABLE 231 WESTROCK COMPANY: COMPANY OVERVIEW
  • TABLE 232 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 233 WESTROCK COMPANY: DEALS
  • TABLE 234 NIPRO: COMPANY OVERVIEW
  • TABLE 235 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 236 NIPRO: PRODUCT LAUNCHES
  • TABLE 237 CATALENT, INC.: COMPANY OVERVIEW
  • TABLE 238 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 239 CATALENT, INC.: DEALS
  • TABLE 240 CATALENT, INC.: EXPANSIONS
  • TABLE 241 SEALED AIR: COMPANY OVERVIEW
  • TABLE 242 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 243 SEALED AIR: PRODUCT LAUNCHES
  • TABLE 244 SEALED AIR: DEALS
  • TABLE 245 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
  • TABLE 246 WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 247 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES
  • TABLE 248 WEST PHARMACEUTICAL SERVICES: DEALS
  • TABLE 249 WEST PHARMACEUTICAL SERVICES: EXPANSIONS
  • TABLE 250 ALPLA: COMPANY OVERVIEW
  • TABLE 251 ARDAGH GROUP S.A.: COMPANY OVERVIEW
  • TABLE 252 CCL INDUSTRIES INC.: COMPANY OVERVIEW
  • TABLE 253 FRANK NOE: COMPANY OVERVIEW
  • TABLE 254 GAPLAST GMBH: COMPANY OVERVIEW
  • TABLE 255 LONZA: COMPANY OVERVIEW
  • TABLE 256 MONDI: COMPANY OVERVIEW
  • TABLE 257 NOLATO AB: COMPANY OVERVIEW
  • TABLE 258 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
  • TABLE 259 COMAR: COMPANY OVERVIEW
  • TABLE 260 BILCARE LIMITED: COMPANY OVERVIEW
  • TABLE 261 SGD PHARMA: COMPANY OVERVIEW
  • TABLE 262 SILGAN PLASTICS: COMPANY OVERVIEW
  • TABLE 263 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 264 SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 STUDY YEARS CONSIDERED
  • FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
  • FIGURE 1 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 2 KEY DATA FROM PRIMARY SOURCES
  • FIGURE 3 KEY INDUSTRY INSIGHTS
  • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
  • FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
  • FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
  • FIGURE 5 RESEARCH ASSUMPTIONS
  • FIGURE 6 LIMITATIONS
  • FIGURE 7 PLASTIC BOTTLES SEGMENT TO LEAD AMONG PACKAGE TYPES IN 2025 AND 2030
  • FIGURE 8 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
  • FIGURE 9 PLASTIC SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 10 INJECTABLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 12 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
  • FIGURE 13 PLASTICS SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 14 PLASTIC BOTTLES SEGMENT TO BE LARGEST MARKET
  • FIGURE 15 PRIMARY PHARMACEUTICAL PACKAGING SEGMENT TO RECORD LARGEST MARKET AND FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 16 INJECTABLES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 17 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM
  • FIGURE 21 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 IMPORT DATA FOR HS CODE 392310-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020-2024 (USD MILLION)
  • FIGURE 24 PATENTS APPLIED AND GRANTED, 2014-2024
  • FIGURE 25 LEGAL STATUS OF PATENTS, 2014-2024
  • FIGURE 26 TOP JURISDICTIONS
  • FIGURE 27 PHARMACEUTICAL PACKAGING MARKET: INVESTOR DEALS AND FUNDING TRENDS, 2020-2024 (USD MILLION)
  • FIGURE 28 PORTER'S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES
  • FIGURE 31 PRIMARY PACKAGING SEGMENT TO DOMINATE OVERALL PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
  • FIGURE 32 PHARMACEUTICAL PLASTIC PACKAGING TO DOMINATE PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
  • FIGURE 33 INJECTABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
  • FIGURE 34 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
  • FIGURE 35 NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 37 PHARMACEUTICAL PACKAGING MARKET SHARE ANALYSIS, 2024
  • FIGURE 38 PHARMACEUTICAL PACKAGING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020-2024 (USD BILLION)
  • FIGURE 39 PHARMACEUTICAL PACKAGING MARKET: COMPANY VALUATION, 2024 (USD BILLION)
  • FIGURE 40 PHARMACEUTICAL PACKAGING MARKET: FINANCIAL MATRIX: EV/EBITDA RATIO, 2024
  • FIGURE 41 PHARMACEUTICAL PACKAGING MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA, 2024
  • FIGURE 42 PHARMACEUTICAL PACKAGING MARKET: PRODUCT/BRAND COMPARISON
  • FIGURE 43 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 PHARMACEUTICAL PACKAGING MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 AMCOR PLC: COMPANY SNAPSHOT
  • FIGURE 47 GERRESHEIMER AG: COMPANY SNAPSHOT
  • FIGURE 48 SCHOTT AG: COMPANY SNAPSHOT
  • FIGURE 49 APTARGROUP, INC.: COMPANY SNAPSHOT
  • FIGURE 50 BD: COMPANY SNAPSHOT
  • FIGURE 51 WESTROCK COMPANY: COMPANY SNAPSHOT
  • FIGURE 52 NIPRO: COMPANY SNAPSHOT
  • FIGURE 53 CATALENT, INC.: COMPANY SNAPSHOT
  • FIGURE 54 SEALED AIR: COMPANY SNAPSHOT
  • FIGURE 55 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!